Last updated on September 2018

Efficacy Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization


Brief description of study

This will be a randomized, placebo-controlled, parallel group, multicenter, Phase III study.The study aims to evaluate the Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects with Critical Limb Ischemia (CLI) with Minor Tissue Loss (Rutherford Category 5) who are Unsuitable for Revascularization.

Clinical Study Identifier: NCT03006770

Contact Investigators or Research Sites near you

Start Over

Matuska Jiri

Cevni ambulance
Hodonín, Czechia
5.87miles
  Connect »